Daniela Heidenreich

Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group

Esther Schuler, Eva‐Maria Wagner‐Drouet, Salem Ajib et al. · Annals of Hematology · 2020 · 65 citations · Full text

In vitro quality control of red blood cell concentrates outdated in clinical practice

R. Zimmermann, Daniela Heidenreich, Volker Weisbach et al. · Transfusion Clinique et Biologique · 2003 · 44 citations

Medicine, Transfusion Medicine, Platelet Concentrates +8

Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation

Eva Wagner-Drouet, Daniel Teschner, Christine Wolschke et al. · Haematologica · 2019 · 44 citations · Full text

Cell Therapy, Cytomegalovirus-specific Cellular Immunity, Immunodeficiencies +19

Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial

Matthias Stelljes, Jan Moritz Middeke, Gesine Bug et al. · The Lancet Haematology · 2024 · 44 citations · Full text

Nilotinib (Tasigna®) and Chemotherapy for First-Line Treatment in Elderly Patients with De Novo Philadelphia Chromosome/BCR-ABL1 Positive Acute Lymphoblastic Leukemia (ALL): A Trial of the European Working Group for Adult ALL (EWALL-PH-02)

Oliver G. Ottmann, Jean‐Michel Cayuela, Karsten Spiekermann et al. · Blood · 2014 · 39 citations